CS248712B2 - Production method of 6 alfa-methylcorticoids - Google Patents

Production method of 6 alfa-methylcorticoids Download PDF

Info

Publication number
CS248712B2
CS248712B2 CS838675A CS867583A CS248712B2 CS 248712 B2 CS248712 B2 CS 248712B2 CS 838675 A CS838675 A CS 838675A CS 867583 A CS867583 A CS 867583A CS 248712 B2 CS248712 B2 CS 248712B2
Authority
CS
Czechoslovakia
Prior art keywords
methylcorticoids
acyloxy
carbon atoms
formula
alfa
Prior art date
Application number
CS838675A
Other languages
Czech (cs)
English (en)
Inventor
Klaus Annen
Henry Laurent
Helmut Hofmeister
Rudolf Wiechert
Hans Wendt
Original Assignee
Schering Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Ag filed Critical Schering Ag
Priority to CS8410074A priority Critical patent/CS248728B2/cs
Priority to CS8410073A priority patent/CS248727B2/cs
Priority to CS8410075A priority patent/CS248729B2/cs
Priority to CS8410076A priority patent/CS248730B2/cs
Publication of CS248712B2 publication Critical patent/CS248712B2/cs

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J21/00—Normal steroids containing carbon, hydrogen, halogen or oxygen having an oxygen-containing hetero ring spiro-condensed with the cyclopenta(a)hydrophenanthrene skeleton
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J5/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond
    • C07J5/0046—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa
    • C07J5/0053—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa not substituted in position 16
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J7/00—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms
    • C07J7/008—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms substituted in position 21
    • C07J7/0085—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms substituted in position 21 by an halogen atom

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pain & Pain Management (AREA)
  • Immunology (AREA)
  • Rheumatology (AREA)
  • Dermatology (AREA)
  • Pulmonology (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Saccharide Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Manufacture Of Tobacco Products (AREA)
  • Seasonings (AREA)
  • Detergent Compositions (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
CS838675A 1982-11-22 1983-11-22 Production method of 6 alfa-methylcorticoids CS248712B2 (en)

Priority Applications (4)

Application Number Priority Date Filing Date Title
CS8410074A CS248728B2 (cs) 1982-11-22 1984-12-20 Způsob výroby derivátů βα-methylkortikoidu
CS8410073A CS248727B2 (cs) 1982-11-22 1984-12-20 Způsob výroby derivátů Ba-methylkortikoidu
CS8410075A CS248729B2 (cs) 1982-11-22 1984-12-20 Způsob výroby derivátů 6a-niethylkortikoidu
CS8410076A CS248730B2 (cs) 1982-11-22 1984-12-20 Způsob výroby derivátů Ba-methylkortikoidu

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19823243482 DE3243482A1 (de) 1982-11-22 1982-11-22 Neue 6(alpha)-methylkortikoide, ihre herstellung und verwendung

Publications (1)

Publication Number Publication Date
CS248712B2 true CS248712B2 (en) 1987-02-12

Family

ID=6178924

Family Applications (1)

Application Number Title Priority Date Filing Date
CS838675A CS248712B2 (en) 1982-11-22 1983-11-22 Production method of 6 alfa-methylcorticoids

Country Status (22)

Country Link
US (1) US4645763A (no)
EP (1) EP0110041B1 (no)
JP (1) JPS59106500A (no)
AT (1) ATE28651T1 (no)
AU (1) AU2098983A (no)
BG (2) BG43867A3 (no)
CA (1) CA1303607C (no)
CS (1) CS248712B2 (no)
DD (1) DD219200A5 (no)
DE (2) DE3243482A1 (no)
DK (1) DK159686C (no)
ES (1) ES526446A0 (no)
GB (1) GB2130587A (no)
GR (1) GR79725B (no)
HU (1) HU190746B (no)
IE (1) IE56281B1 (no)
IL (1) IL70160A (no)
NO (1) NO157454C (no)
PL (3) PL138796B1 (no)
PT (1) PT77408B (no)
RO (2) RO93593B (no)
ZA (1) ZA838720B (no)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS60161914A (ja) * 1984-02-02 1985-08-23 Green Cross Corp:The ステロイド脂肪酸エステル含有直腸投与製剤
JPS61274795A (ja) * 1985-05-30 1986-12-04 Toshiba Corp 曝気槽の溶存酸素濃度制御装置
US4968822A (en) * 1987-12-11 1990-11-06 Taisho Pharmaceutical Co., Ltd. 21-alkoxysteroid compounds
WO1991014700A2 (en) * 1990-03-27 1991-10-03 Schering Corporation PROCESS FOR 9α-HYDROXY STEROID DEHYDRATION
DE4333920A1 (de) * 1993-10-05 1995-04-13 Hoechst Ag Corticoid-17,21-dicarbonsäureester sowie Corticosteroid-17-carbonsäureester-21-kohlensäureester, Verfahren zu deren Herstellung und diese enthaltende Arzneimittel
ITMI20011762A1 (it) 2001-08-10 2003-02-10 Cosmo Spa Esteri di 17alfa,21-diidrossipregnene, loro uso come agenti anti-androgenetici e procedimenti per la loro preparazione
ITMI20071616A1 (it) 2007-08-03 2009-02-04 Cosmo Spa Processo enzimatico per l'ottenimento di 17-alfa monoesteri del cortexolone e/o suoi 9,11-deidroderivati.
EP3656385A1 (en) * 2008-05-28 2020-05-27 ReveraGen BioPharma, Inc. Non-hormonal steroid modulators of nf-kb for treatment of disease
WO2011127048A2 (en) 2010-04-05 2011-10-13 Validus Biopharma NON-HORMONAL STEROID MODULATORS OF NF-ĸB FOR TREATMENT OF DISEASE
EP3108879A1 (en) 2015-06-25 2016-12-28 Cassiopea S.p.A. High concentration formulation
US10799514B2 (en) 2015-06-29 2020-10-13 Reveragen Biopharma, Inc. Non-hormonal steroid modulators of NF-kappa beta for treatment of disease
US11382922B2 (en) 2019-03-07 2022-07-12 Reveragen Biopharma, Inc. Aqueous oral pharmaceutical suspension compositions

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3053832A (en) * 1957-04-29 1962-09-11 Schering Corp Alkylated cortical steroids
GB921533A (en) * 1958-07-12 1963-03-20 Syntex Sa Cyclopentanophenanthrene derivatives and process for the production thereof
GB1047518A (en) * 1963-06-11 1966-11-02 Glaxo Lab Ltd 17ª‡-monoesters of 11,17,21-trihydroxy steroid compounds
DE2645104C2 (de) * 1976-10-04 1986-04-24 Schering AG, 1000 Berlin und 4709 Bergkamen 11β-Hydroxy-1,4,8-pregnatrien-3,20-dion-Derivate und Verfahren zu ihrer Herstellung
US4243586A (en) * 1980-01-18 1981-01-06 E. R. Squibb & Sons, Inc. Steroidal-17-spiro-dihydrofuranones
US4318853A (en) * 1980-01-31 1982-03-09 The Upjohn Company 9β,11β-Epoxy-5β-corticoids
US4336200A (en) * 1980-01-31 1982-06-22 The Upjohn Company 17α-Acyloxy-5β-corticoids
ATE12237T1 (de) * 1980-12-23 1985-04-15 Schering Ag Neue 6-alpha-methylhydrocortison-derivate, ihre herstellung und verwendung.

Also Published As

Publication number Publication date
JPS59106500A (ja) 1984-06-20
IL70160A (en) 1988-03-31
ES8405421A1 (es) 1984-06-16
ZA838720B (en) 1984-07-25
PL244685A1 (en) 1985-04-24
CA1303607C (en) 1992-06-16
DK533783A (da) 1984-05-23
DK533783D0 (da) 1983-11-22
BG42677A3 (en) 1988-01-15
ATE28651T1 (de) 1987-08-15
IE56281B1 (en) 1991-06-05
IL70160A0 (en) 1984-02-29
DK159686C (da) 1991-04-15
ES526446A0 (es) 1984-06-16
IE832708L (en) 1984-05-22
BG43867A3 (en) 1988-08-15
AU2098983A (en) 1984-05-31
RO93593B (ro) 1988-01-01
NO157454B (no) 1987-12-14
NO834265L (no) 1984-05-23
US4645763A (en) 1987-02-24
PT77408B (de) 1986-02-27
DE3243482A1 (de) 1984-05-24
EP0110041A1 (de) 1984-06-13
PL138796B1 (en) 1986-11-29
HU190746B (en) 1986-10-28
DK159686B (da) 1990-11-19
PT77408A (de) 1983-10-01
PL250734A1 (en) 1985-07-30
RO89343A (ro) 1986-03-15
GB8327736D0 (en) 1983-11-16
EP0110041B1 (de) 1987-07-29
PL141686B1 (en) 1987-08-31
GR79725B (no) 1984-10-31
DE3372776D1 (en) 1987-09-03
NO157454C (no) 1988-03-23
GB2130587A (en) 1984-06-06
RO93593A (ro) 1987-12-31
PL250735A1 (en) 1985-07-30
DD219200A5 (de) 1985-02-27
JPH0415799B2 (no) 1992-03-19

Similar Documents

Publication Publication Date Title
DE2711493C2 (no)
RU2361601C2 (ru) Композиция для лечения атопических дерматитов, аллергических состояний кожи и угрей
CS248712B2 (en) Production method of 6 alfa-methylcorticoids
Hasan et al. Asparagus racemosus: for medicinal uses & pharmacological actions
WO1994023722A1 (en) Hydrocortisone buffering activity
KR20120047240A (ko) 주사 또는 홍안 관련 피부 질환의 치료를 위한, 베르베린 또는 그의 유사체를 함유하는 조성물
RO120950B1 (ro) Complex bioactiv de acizi triterpenici, procedeu de obţinere şi produse medicamentoase cu utilizări terapeutice
JPH0344048B2 (no)
WO2008148572A1 (de) Antiinflammatorische wirkstoffkombinationen zur behandlung von erkrankungen der haut und schleimhäute
EP2723344B1 (de) Monoterpenhaltiges kombinationstherapeutikum
CH650153A5 (de) Saponinhaltiges praeparat, das gegen nebennieren-atrophie wirksam ist.
EP0988040B1 (en) Use of glucosamine and glucosamine derivatives for quick alleviation of itching or localized pain
EP0527241B1 (de) Verwendung der Ascorbinsäure zur Zubereitung von Arzneimitteln zur Anwendung im Genitalbereich
DE2206570C3 (de) Verwendung von (+)-Catechin
NZ536360A (en) Compositions for therapeutic use comprising a vitamin, a metal salt and insulin or a growth hormone
KR890000093A (ko) 건선의 치료방법 및 치료용 조성물
EP1275382A2 (de) Hyperforin als Zytostatikum sowie Hyperforin-Salbe oder -Creme als Applikationsform
ITMI20070561A1 (it) Composizioni transdermiche o transmucosali contenenti composti a struttura steroidea
CN101012267A (zh) 甘草酸苦参碱盐和甘草酸苦参素盐及其制备方法和用途
JPH04505160A (ja) 抗菌剤としてのステロイド化合物の使用
DE102020131716A1 (de) Neues Therapiekonzept für die Behandlung von Corona-Infektionen, insbesondere COVID-19-Infektionen
EP1212072B1 (de) Pharmazeutische zusammensetzung, umfassend eukalyptus- und orangenöl
EP4216944B1 (de) Neues therapiekonzept für die behandlung von corona-infektionen, insbesondere covid-19-infektionen
DE19848303A1 (de) Kombination aus Gestagenen und Zuckern
HU196122B (en) Process for preparing pharmaceuticals comprising 9alpha, 11beta-dichlor-16alpha-methyl-21-(dicyclohexyl-methyloxy-carbonyloxy)-pregno-1,4-dien-3,20-dione